Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
 Medical News
-Blood Safety News
 NHF and Community News
 Industry News
 Travel Advisory

 

 

 
Canadian Government Drops Remaining Charges Against Perrault
 

Nearly two years after the criminal trial first began on February 2006, prosecutors for the Canadian government have dropped all remaining charges against Roger Perrault, former director of the Canadian Red Cross (CRC). The charges stem from Canada’s contaminated blood scandals of the 1980s and early 1990s. 

Approximately 1,000 Canadians were infected with HIV and an additional 20,000 with hepatitis C (HCV) when they inadvertently used contaminated blood and blood products. The majority of the HIV infections occurred in the 1980s, while the HCV infections occurred from the 1970s to the early 1990s. Complications related to HIV and HCV have resulted in the deaths of at least 3,000 Canadians.

In May 2005, CRC pled guilty to federal charges filed in 2002 under Canada’s Food and Drug Act for distributing products tainted with HIV and HCV from 1983 to 1990. It paid the maximum fine allowed under the offense. In addition, CRC agreed to contribute 1.5 million Canadian dollars ($1.4 million) to the University of Ottawa; with half the money going to a scholarship fund for victims and their families and the other half to a “national medical error project” to prevent such a crisis in the future.

In 1998, the Canadian government established a one billion Canadian dollars ($970 million) trust for HCV victims. The fund, initially open only to those infected with HCV from 1986-1990, was expanded in 2006 to include all Canadian citizens who contracted HCV from contaminated blood or blood-derived products.

While the compensation packages were welcome developments, the existing charges against Perrault represented for many a chance for accountability. Instead, Perrault’s “exoneration” is difficult for victims and their advocates to accept. They hold the former CRC blood transfusion service director largely responsible for allowing contaminated blood products to infect patients in the 1980s and early 1990s.

Also acquited in that decision were John Furesz, former director of the Bureau of Biologics at Health Canada; Wark Boucher, former chief of the blood products division of the Bureau of Biologics; Michael Rodell, former Armour Pharmaceutical vice president; and Armour Pharmaceutical, the New Jersey-based manufacturer of Factorate, the factor VIII product sold in Canada. In November 1987, Armour withdrew Factorate from the Canadian market in response to evidence that the heat-based, viral inactivation process being used did not adequately kill HIV.

The Canadian Hemophilia Society (CHS), which represents the country’s bleeding disorders population, reacted to the government’s latest move with indignation.

“A lot of money and time was spent and it all just ended today with a 10-minute speech from the Crown,” said John Plater of CHS. “There are a lot of people out there that are hurting as a result of what happened and they are going to walk away from this very confused, very upset, with a lot of questions. People can say that the system has failed them once again.”

Source: The Toronto Star (online), January 19, 2008, and Medical News Today, January 24, 2008

 

This section of our Web site is sponsored by: